AstraZeneca Pharmaceuticals (Ireland) DAC (AstraZeneca)

Lobbying Organisation AstraZeneca Pharmaceuticals (Ireland) DAC

Date published 20 May, 2023

Relevant Matter Legislation

Public Policy Area Health

Period 1 Jan, 2023 to 30 Apr, 2023

Specific Details High Tech medicines policy in Ireland

Intended results Sharing views on policy reform to facilitate swifter access to high-tech treatments for patients of high and critical unmet need

Name of person primarily responsible for lobbying on this activity Colin O'Donnell

Did any Designated Public Official(DPO) or former Designated Public Official(DPO) carry out lobbying activities on your behalf in relation to this return? You must include yourself, and answer Yes, if you are a current DPO or a DPO at any time in the past. (What is a Designated Public Official?) No

Did you manage or direct a grassroots campaign? No

Was this lobbying done on behalf of a client? No

Lobbying activity

The following activities occurred for this specific Subject Matter Area.

Meeting (6-10)

Met with stakeholders on High Tech medicines policy in Ireland

Email (2-5)

Provided briefing via email to stakeholders on High Tech medicines policy in Ireland

Phone call (2-5)

Calls to stakeholders on High Tech medicines policy in Ireland

Designated public officials lobbied

The following DPOs were lobbied during this return period on this specific Subject Matter Area. These DPOs were involved in at least one of the Lobbying Activities listed above, but not necessarily all of them. As returns are specific to a Subject Matter Area the above Lobbying Activities may be associated with multiple returns.

Colm Burke TD (Dáil Éireann, the Oireachtas)

Pádraig O'Sullivan TD (Dáil Éireann, the Oireachtas)

John Lahart TD (Dáil Éireann, the Oireachtas)

Annie Hoey Senator (Seanad)

Erin McGreehan Senator (Seanad)

Catherine Ardagh Senator (Seanad)

Thomas Pringle TD (Dáil Éireann, the Oireachtas)